Impulse control disorders in patients with dopamine agonist‐treated prolactinomas and nonfunctioning pituitary adenomas: a case–control study
Irina Bancos(Mayo Clinic in Arizona), Todd B. Nippoldt(Mayo Clinic in Arizona), Dana Erickson(Mayo Clinic), Michael H. Silber(Mayo Clinic), John Bostwick(Mayo Clinic), Michael R. Nannenga(Holston Valley Medical Center)
Cited by 135
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2023|654
Diagnosis and management of adrenal insufficiency
|The Lancet Diabetes & Endocrinology|2014|451
Consensus on diagnosis and management of Cushing's disease: a guideline update
|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021|351
Diagnosis and treatment of primary aldosteronism
|The Lancet Diabetes & Endocrinology|2021|319